美股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

避孕概念

1,949.57

-9.4929-0.48%

涨家数：2

跌家数：4

平家数：- -

市盈率：- -

高：1,971.73

开：1,959.02

低：1,911.66

收：1,959.07

成交量：1,746.96万

成交额：2.81亿

市值：308.47亿

流通市值：306.52亿

数据加载中...

总览新闻资讯

Dare Bioscience, Inc.盘中异动股价大跌5.01%

Femasys Inc.盘中异动早盘股价大涨5.78%

Sanara Medtech Inc.盘中异动急速拉升5.36%报29.20美元

BUZZ-停止肺病药物后期试验后，MannKind业绩下滑

Stereotaxis, Inc.盘中异动股价大涨5.33%

曼恩凯德生物医疗股价在盘前交易中下跌5.7%，因公司决定中止肺病治疗的第三阶段临床试验

MannKind：在三期ICON-1试验中未观察到转化情况，因而对实现研究主要终点的可能性产生担忧

Femasys Inc.盘中异动早盘股价大涨5.13%

登士柏盘中异动早盘股价大跌11.41%报11.18美元

梯瓦制药盘中异动快速拉升12.90%报23.10美元

Innovative Eyewear Inc C/Wts 16/08/2027 (To Pur Com) Ser A股价上涨12.40% 市值涨3.15万美元

Femasys：将利用1200万美元债券收益来再融资现有债务，推动公司生育及永久避孕产品的商业化

Femasys Inc：协议发行1200万美元的高级担保可转换票据，并提供5800万美元的普通股认购权

Femasys Inc：与部分机构和合格投资者达成最终协议，投资由现有投资者Jorey Chernett主导

Femasys获FDA批准推进Fembloc®最终试验阶段及1200万美元融资，有望达到5800万美元

新闻稿：Dare Bioscience将获得最高30万美元进行全球避孕创新能力评估

Dare Bioscience, Inc.盘中异动股价大涨5.18%

梯瓦制药召回超58万瓶盐酸哌唑嗪

环球市场播报

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/hans/stock/BK4584/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4584","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4584\",,,,,undefined,":{"symbol":"BK4584","market":"US","secType":"PLATE","nameCN":"避孕概念","latestPrice":1949.5741,"timestamp":1763153999999,"preClose":1959.067,"halted":0,"volume":17469627,"delay":0,"changeRate":-0.004846,"floatShares":0,"shares":0,"eps":0,"marketStatus":"未开盘","change":-9.49292,"latestTime":"11-14 16:00:00 EST","open":1959.0165,"high":1971.7333,"low":1911.6605,"amount":280734176.440704,"amplitude":0.030664,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1763389800000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":4.269492,"peRate":51.042736,"turnoverRate":0.011543,"increases":2,"decrements":4,"flats":0,"marketCap":30847186930,"floatMarketCap":30651851850},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4584\",,,,,undefined,":{"symbol":"BK4584","high":1971.7333,"amplitude":0.030664,"preClose":1959.067,"low":1911.6605,"pbRate":"4.269492","latestPrice":1949.5741,"volume":17469627,"delay":0,"open":1959.0165,"prevYearClose":1682.2216,"prevWeekClose":1949.5741,"prevMonthClose":1603.655,"prevQuarterClose":1579.0345,"fiveDayClose":1856.8206,"twentyDayClose":1517.5698,"sixtyDayClose":1449.9128,"secType":"PLATE","market":"US","turnoverRate":0.011543,"peRate":51.042736,"marketCap":30847186930,"floatMarketCap":30651851850,"timestamp":1763153999999,"nameCN":"避孕概念"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4584\",,,,undefined,":{"bkCode":"BK4584","up":2,"down":4,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4584\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2583548693","title":"Dare Bioscience, Inc.盘中异动 股价大跌5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2583548693","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583548693?lang=zh_cn&edition=fundamental","pubTime":"2025-11-14 04:40","pubTimestamp":1763066423,"startTime":"0","endTime":"0","summary":"北京时间2025年11月14日04时40分，Dare Bioscience, Inc.股票出现异动，股价大幅跳水5.01%。Dare Bioscience, Inc.股票所在的生物技术行业中，整体涨幅为0.18%。其相关个股中，Mersana Therapeutics, Inc.、Lexaria Bioscience Corp C/Wts 14/01/2026 、冠科美博涨幅较大，Clearmind Medicine Inc.、Salarius Pharmaceuticals, Inc.、Galecto, Inc.较为活跃，换手率分别为5380.76%、508.38%、132.98%，振幅较大的相关个股有Clearmind Medicine Inc.、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 、冠科美博，振幅分别为107.67%、56.78%、48.97%。Dare Bioscience, Inc.公司简介：Dare Bioscience Inc 是一家致力于推进女性健康产品的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511140440239767ccb5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511140440239767ccb5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4584","DARE","BK4007"],"gpt_icon":0},{"id":"2583534848","title":"Femasys Inc.盘中异动 早盘股价大涨5.78%","url":"https://stock-news.laohu8.com/highlight/detail?id=2583534848","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583534848?lang=zh_cn&edition=fundamental","pubTime":"2025-11-12 22:30","pubTimestamp":1762957825,"startTime":"0","endTime":"0","summary":"北京时间2025年11月12日22时30分，Femasys Inc.股票出现波动，股价快速上涨5.78%。Femasys Inc.股票所在的医疗设备行业中，整体涨幅为0.00%。其相关个股中，Innovative Eyewear, Inc.、爱尔康、Cuprina Holdings  Limited涨幅较大，Innovative Eyewear, Inc.、Cuprina Holdings  Limited、Femasys Inc.较为活跃，换手率分别为133.77%、0.66%、0.42%，振幅较大的相关个股有Femasys Inc.、Nexgel, Inc、Innovative Eyewear, Inc.，振幅分别为3.70%、3.51%、3.25%。Femasys Inc.公司简介：Femasys Inc一家生物医学公司，专注于通过开发解决方案和进步来改变女性医疗保健，为严重服务不足的地区提供临床影响。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025111222302595001768&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025111222302595001768&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4584","BK4082","FEMY"],"gpt_icon":0},{"id":"2582387185","title":"Sanara Medtech Inc.盘中异动 急速拉升5.36%报29.20美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2582387185","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582387185?lang=zh_cn&edition=fundamental","pubTime":"2025-11-11 01:03","pubTimestamp":1762794213,"startTime":"0","endTime":"0","summary":"北京时间2025年11月11日01时03分，Sanara Medtech Inc.股票出现异动，股价快速上涨5.36%。截至发稿，该股报29.20美元/股，成交量1.0201万股，换手率0.11%，振幅2.16%。Sanara Medtech Inc.股票所在的医疗设备行业中，整体涨幅为0.15%。Sanara Medtech Inc.公司简介：Sanara MedTech Inc 是一家医疗技术公司，专注于开发和商业化变革性技术，以改善临床结果并减少慢性和手术伤口和护肤市场的医疗保健支出。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025111101033394fbcb34&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025111101033394fbcb34&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4584","BK4082","BK4198","SMTI","BK4539","FEMY"],"gpt_icon":0},{"id":"2582980851","title":"BUZZ-停止肺病药物后期试验后，MannKind业绩下滑","url":"https://stock-news.laohu8.com/highlight/detail?id=2582980851","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582980851?lang=zh_cn&edition=fundamental","pubTime":"2025-11-10 23:20","pubTimestamp":1762788055,"startTime":"0","endTime":"0","summary":"11月10日 - ** 制药商MannKindMNKD.O的股价下跌7.5%，至5.2美元，该公司停止了 。** MNKD 年内下跌 18(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251110:nL4T3WM1AL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4584","BK4139","MNKD"],"gpt_icon":0},{"id":"2582387133","title":"Stereotaxis, Inc.盘中异动 股价大涨5.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2582387133","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582387133?lang=zh_cn&edition=fundamental","pubTime":"2025-11-10 22:31","pubTimestamp":1762785075,"startTime":"0","endTime":"0","summary":"北京时间2025年11月10日22时31分，Stereotaxis, Inc.股票出现波动，股价大幅上涨5.33%。截至发稿，该股报2.87美元/股，成交量4.5117万股，换手率0.05%，振幅1.10%。Stereotaxis, Inc.股票所在的医疗设备行业中，整体涨幅为0.29%。其相关个股中，Nyxoah Sa、Stereotaxis, Inc.、Microbot Medical Inc.涨幅较大，Femasys Inc.、Microbot Medical Inc.、Bionano Genomics, Inc.较为活跃，换手率分别为3.16%、0.45%、0.32%，振幅较大的相关个股有Femasys Inc.、Nephros, Inc.、Daxor Corporation，振幅分别为6.57%、6.09%、3.89%。Stereotaxis, Inc.公司简介：Stereotaxis Inc从事机器人技术，旨在加强对心律失常的治疗并执行血管内手术。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251110223115a6efbdb0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251110223115a6efbdb0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["STXS","BK4539","FEMY","BK4584","BK4082"],"gpt_icon":0},{"id":"1169320260","title":"曼恩凯德生物医疗股价在盘前交易中下跌5.7%，因公司决定中止肺病治疗的第三阶段临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=1169320260","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1169320260?lang=zh_cn&edition=fundamental","pubTime":"2025-11-10 21:15","pubTimestamp":1762780554,"startTime":"0","endTime":"0","summary":"曼恩凯德生物医疗的股价在盘前交易中下跌5.7%，原因是公司宣布将中止针对肺病治疗的第三阶段临床试验。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4584","MNKD","BK4139"],"gpt_icon":0},{"id":"1128732960","title":"MannKind：在三期ICON-1试验中未观察到转化情况，因而对实现研究主要终点的可能性产生担忧","url":"https://stock-news.laohu8.com/highlight/detail?id=1128732960","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1128732960?lang=zh_cn&edition=fundamental","pubTime":"2025-11-10 21:06","pubTimestamp":1762779992,"startTime":"0","endTime":"0","summary":"MannKind：在三期ICON-1试验中未观察到转化情况，因而对实现研究主要终点的可能性产生担忧","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MNKD","BK4584","BK4139"],"gpt_icon":0},{"id":"2581529638","title":"Femasys Inc.盘中异动 早盘股价大涨5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2581529638","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581529638?lang=zh_cn&edition=fundamental","pubTime":"2025-11-07 23:17","pubTimestamp":1762528651,"startTime":"0","endTime":"0","summary":"北京时间2025年11月07日23时17分，Femasys Inc.股票出现波动，股价急速拉升5.13%。Femasys Inc.股票所在的医疗设备行业中，整体跌幅为0.28%。其相关个股中，ICU医疗、Femasys Inc.、Solventum Corporation涨幅较大，Femasys Inc.、哈佛生物科学、ICU医疗较为活跃，换手率分别为2.23%、1.44%、1.18%，振幅较大的相关个股有Anbio Biotechnology、中进医疗、ICU医疗，振幅分别为19.25%、11.67%、10.40%。Femasys Inc.公司简介：Femasys Inc一家生物医学公司，专注于通过开发解决方案和进步来改变女性医疗保健，为严重服务不足的地区提供临床影响。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025110723173194f5fb0f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025110723173194f5fb0f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4584","BK4082","FEMY","BK4539"],"gpt_icon":0},{"id":"2581043763","title":"登士柏盘中异动 早盘股价大跌11.41%报11.18美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2581043763","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581043763?lang=zh_cn&edition=fundamental","pubTime":"2025-11-06 22:31","pubTimestamp":1762439510,"startTime":"0","endTime":"0","summary":"北京时间2025年11月06日22时31分，登士柏股票出现波动，股价快速下挫11.41%。截至发稿，该股报11.18美元/股，成交量37.7487万股，换手率0.19%，振幅2.85%。登士柏股票所在的医疗设备行业中，整体跌幅为0.45%。登士柏公司简介：登士柏西诺德是全球最大的牙科设备和耗材制造商之一。它是由登士柏国际和西诺德牙科系统于2016年对等合并而成的结果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251106223150a48dad49&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251106223150a48dad49&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FEMY","BK4584","BK4585","BK4539","BK4588","BK4198","XRAY","BK4082"],"gpt_icon":0},{"id":"2581828900","title":"梯瓦制药盘中异动 快速拉升12.90%报23.10美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2581828900","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581828900?lang=zh_cn&edition=fundamental","pubTime":"2025-11-05 22:33","pubTimestamp":1762353194,"startTime":"0","endTime":"0","summary":"北京时间2025年11月05日22时33分，梯瓦制药股票出现异动，股价急速拉升12.90%。截至发稿，该股报23.10美元/股，成交量366.374万股，换手率0.32%，振幅0.98%。机构评级方面，在所有10家参与评级的机构中，90%的券商给予买入建议，10%的券商给予卖出建议，无券商给予持有建议。梯瓦制药股票所在的制药行业中，整体涨幅为0.57%。梯瓦还销售活性药物成分，提供合同制造服务，并拥有美国仿制药和特种药分销商Anda。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251105223314a6e3773f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251105223314a6e3773f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","BK4566","LU1983299246.USD","TEVA","BK4007","BK4557","BK4585","BK4596","BK4584","BK4559"],"gpt_icon":0},{"id":"2580780652","title":"Innovative Eyewear Inc C/Wts 16/08/2027 (To Pur Com) Ser A股价上涨12.40% 市值涨3.15万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2580780652","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580780652?lang=zh_cn&edition=fundamental","pubTime":"2025-11-04 01:26","pubTimestamp":1762190760,"startTime":"0","endTime":"0","summary":"北京时间2025年11月04日01时26分，Innovative Eyewear Inc C/Wts 16/08/2027  Ser A股票出现波动，股价大幅拉升12.40%。Innovative Eyewear Inc C/Wts 16/08/2027  Ser A股票所在的医疗设备行业中，整体跌幅为0.35%。Innovative Eyewear Inc C/Wts 16/08/2027  Ser A公司简介：Innovative Eyewear Inc 从事眼镜和太阳镜的开发和销售，这些产品旨在让客户在享受数字生活的同时，也能提供处方镜片和防晒保护。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251104012601a485a871&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251104012601a485a871&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LUCYW","BK4539","BK4584","BK4082","FEMY"],"gpt_icon":0},{"id":"1130302363","title":"Femasys：将利用1200万美元债券收益来再融资现有债务，推动公司生育及永久避孕产品的商业化","url":"https://stock-news.laohu8.com/highlight/detail?id=1130302363","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1130302363?lang=zh_cn&edition=fundamental","pubTime":"2025-11-03 21:35","pubTimestamp":1762176918,"startTime":"0","endTime":"0","summary":"Femasys：将利用1200万美元债券收益来再融资现有债务，推动公司生育及永久避孕产品的商业化。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FEMY","BK4082","BK4539","BK4584"],"gpt_icon":0},{"id":"1180165234","title":"Femasys Inc：协议发行1200万美元的高级担保可转换票据，并提供5800万美元的普通股认购权","url":"https://stock-news.laohu8.com/highlight/detail?id=1180165234","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1180165234?lang=zh_cn&edition=fundamental","pubTime":"2025-11-03 21:34","pubTimestamp":1762176849,"startTime":"0","endTime":"0","summary":"Femasys Inc：协议发行1200万美元的高级担保可转换票据，并提供5800万美元的普通股认购权。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4584","BK4539","FEMY","BK4082"],"gpt_icon":0},{"id":"1185023284","title":"Femasys Inc：与部分机构和合格投资者达成最终协议，投资由现有投资者Jorey Chernett主导","url":"https://stock-news.laohu8.com/highlight/detail?id=1185023284","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1185023284?lang=zh_cn&edition=fundamental","pubTime":"2025-11-03 21:33","pubTimestamp":1762176790,"startTime":"0","endTime":"0","summary":"Femasys Inc：与部分机构和合格投资者达成最终协议，投资由现有投资者Jorey Chernett主导","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FEMY","BK4539","BK4082","BK4584"],"gpt_icon":0},{"id":"1163888015","title":"Femasys获FDA批准推进Fembloc®最终试验阶段及1200万美元融资，有望达到5800万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1163888015","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1163888015?lang=zh_cn&edition=fundamental","pubTime":"2025-11-03 21:31","pubTimestamp":1762176673,"startTime":"0","endTime":"0","summary":"Femasys获FDA批准推进Fembloc®最终试验阶段及1200万美元融资，有望达到5800万美元","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","BK4539","FEMY","BK4584"],"gpt_icon":0},{"id":"1130602402","title":"新闻稿：Dare Bioscience将获得最高30万美元进行全球避孕创新能力评估","url":"https://stock-news.laohu8.com/highlight/detail?id=1130602402","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1130602402?lang=zh_cn&edition=fundamental","pubTime":"2025-11-03 21:02","pubTimestamp":1762174971,"startTime":"0","endTime":"0","summary":"圣地亚哥，2025年11月3日— Dare Bioscience, Inc.，一家致力于填补女性健康领域科学与现实解决方案之间差距的健康生物科技公司，今天宣布与比尔和梅琳达·盖茨基金会签订了一项合同，最多可获得约30万美元资金，以开展与避孕产品开发相关的组织能力的战略评估。在此合同框架下，Dare将致力于识别和评估全球范围内具有配方开发、临床和商业制造、临床试验设计以及避孕产品的监管支持等能力的营利性和非营利性组织。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DARE","BK4007","BK4584"],"gpt_icon":0},{"id":"2580492983","title":"Dare Bioscience, Inc.盘中异动 股价大涨5.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2580492983","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580492983?lang=zh_cn&edition=fundamental","pubTime":"2025-10-31 22:41","pubTimestamp":1761921700,"startTime":"0","endTime":"0","summary":"北京时间2025年10月31日22时41分，Dare Bioscience, Inc.股票出现异动，股价急速拉升5.18%。Dare Bioscience, Inc.股票所在的生物技术行业中，整体跌幅为0.18%。其相关个股中，Yd Bio Ltd C/Wts 28/08/2030、Ardelyx, Inc.、Rani Therapeutics Holdings, Inc.涨幅较大，Aditxt, Inc.、Intensity Therapeutics, Inc.、Clearmind Medicine Inc.较为活跃，换手率分别为977.04%、287.52%、141.64%，振幅较大的相关个股有Yd Bio Ltd C/Wts 28/08/2030、Surrozen Inc C/Wts 01/08/2031 、Intensity Therapeutics, Inc.，振幅分别为67.65%、48.04%、29.08%。Dare Bioscience, Inc.公司简介：Dare Bioscience Inc 是一家致力于推进女性健康产品的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251031224141974c7b30&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251031224141974c7b30&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4584","DARE","BK4007"],"gpt_icon":0},{"id":"2579498458","title":"梯瓦制药召回超58万瓶盐酸哌唑嗪","url":"https://stock-news.laohu8.com/highlight/detail?id=2579498458","media":"环球市场播报","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579498458?lang=zh_cn&edition=fundamental","pubTime":"2025-10-31 22:19","pubTimestamp":1761920340,"startTime":"0","endTime":"0","summary":"梯瓦制药（Teva Pharmaceutical Industries，TEVA）上涨0.7%。美国FDA提示亚硝胺污染风险后，梯瓦制药自愿召回超58万瓶盐酸哌唑嗪，本次召回属II类风险。\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：张俊 SF065","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2025-10-31/doc-infvvcyr4247885.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4559","BK4007","BK4588","TEVA","BK4566","BK4557","BK4584","BK4585","LU1983299246.USD","BK4596"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":18,"code":"91000000","status":"200"}]}}